Insider Transactions in Q4 2024 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
20,000
+2.08%
|
$80,000
$4.44 P/Share
|
|
Nov 11
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,400
-0.02%
|
$12,000
$5.0 P/Share
|
|
Nov 11
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-0.02%
|
$12,000
$5.0 P/Share
|
|
Nov 06
2024
|
Christina Ackermann Director |
BUY
Open market or private purchase
|
Direct |
41,880
+50.0%
|
$167,520
$4.74 P/Share
|
|
Nov 06
2024
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
39,360
+4.1%
|
$157,440
$4.8 P/Share
|
|
Nov 04
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
80,784
-0.56%
|
$323,136
$4.39 P/Share
|
|
Nov 04
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
94,144
-0.62%
|
$376,576
$4.39 P/Share
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
48,888
-0.34%
|
$195,552
$4.38 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
46,888
-0.31%
|
$187,552
$4.38 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
245,952
-1.58%
|
$983,808
$4.24 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.27%
|
-
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
245,952
-1.68%
|
$983,808
$4.24 P/Share
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.35%
|
-
|
|
Nov 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65,936
-2.21%
|
$263,744
$4.24 P/Share
|
|
Nov 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.65%
|
-
|
|
Oct 30
2024
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.94%
|
-
|
|
Oct 30
2024
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+5.24%
|
-
|
|
Oct 30
2024
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+9.3%
|
-
|
|
Oct 30
2024
|
Andrew Fisher General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Oct 25
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
4,800
-0.03%
|
$19,200
$4.38 P/Share
|
|
Oct 25
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,200
-0.02%
|
$12,800
$4.38 P/Share
|
|
Oct 24
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
140,000
-0.95%
|
$560,000
$4.38 P/Share
|
|
Oct 24
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
141,360
-1.02%
|
$565,440
$4.38 P/Share
|
|
Oct 23
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
16
-0.0%
|
$64
$4.38 P/Share
|
|
Oct 22
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
159,344
-1.14%
|
$637,376
$4.38 P/Share
|
|
Oct 22
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
157,912
-1.06%
|
$631,648
$4.39 P/Share
|
|
Oct 21
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116,696
-0.83%
|
$466,784
$4.38 P/Share
|
|
Oct 21
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
110,456
-0.74%
|
$441,824
$4.38 P/Share
|
|
Oct 18
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
249,728
-1.74%
|
$998,912
$4.38 P/Share
|
|
Oct 18
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
245,784
-1.61%
|
$983,136
$4.38 P/Share
|